132 related articles for article (PubMed ID: 32176628)
1. The interactome of the prostate-specific protein Anoctamin 7.
Kaikkonen E; Takala A; Pursiheimo JP; Wahlström G; Schleutker J
Cancer Biomark; 2020; 28(1):91-100. PubMed ID: 32176628
[TBL] [Abstract][Full Text] [Related]
2. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer.
Marx A; Koopmann L; Höflmayer D; Büscheck F; Hube-Magg C; Steurer S; Eichenauer T; Clauditz TS; Wilczak W; Simon R; Sauter G; Izbicki JR; Huland H; Heinzer H; Graefen M; Haese A; Schlomm T; Bernreuther C; Lebok P; Bonk S
Cancer Biol Med; 2021 Feb; 18(1):245-255. PubMed ID: 33628598
[TBL] [Abstract][Full Text] [Related]
3. Transcripts of the Prostate Cancer-Associated Gene
Metsälä O; Wahlström G; Taimen P; Kellokumpu-Lehtinen PL; Schleutker J
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674564
[TBL] [Abstract][Full Text] [Related]
4. ANO7: Insights into topology, function, and potential applications as a biomarker and immunotherapy target.
Guo J; Wang D; Dong Y; Gao X; Tong H; Liu W; Zhang L; Sun M
Tissue Cell; 2021 Oct; 72():101546. PubMed ID: 33940566
[TBL] [Abstract][Full Text] [Related]
5. ANO7 is associated with aggressive prostate cancer.
Kaikkonen E; Rantapero T; Zhang Q; Taimen P; Laitinen V; Kallajoki M; Jambulingam D; Ettala O; Knaapila J; Boström PJ; Wahlström G; Sipeky C; Pursiheimo JP; Tammela T; Kellokumpu-Lehtinen PL; ; Fey V; Maehle L; Wiklund F; Wei GH; Schleutker J
Int J Cancer; 2018 Nov; 143(10):2479-2487. PubMed ID: 30157291
[TBL] [Abstract][Full Text] [Related]
6. Expression of anoctamin 7 (ANO7) is associated with poor prognosis and mucin 2 (MUC2) in colon adenocarcinoma: a study based on TCGA data.
Chen C; Aluksanasuwan S; Somsuan K
Genomics Inform; 2023 Dec; 21(4):e46. PubMed ID: 38224713
[TBL] [Abstract][Full Text] [Related]
7. The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression.
Wahlström G; Heron S; Knuuttila M; Kaikkonen E; Tulonen N; Metsälä O; Löf C; Ettala O; Boström PJ; Taimen P; Poutanen M; Schleutker J
Hum Mol Genet; 2022 Jun; 31(12):2063-2077. PubMed ID: 35043958
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of mammalian sterile 20-like kinase 1 by heat shock protein 70 mediates cisplatin resistance in prostate cancer cells.
Ren A; Yan G; You B; Sun J
Cancer Res; 2008 Apr; 68(7):2266-74. PubMed ID: 18381433
[TBL] [Abstract][Full Text] [Related]
9. HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells.
Dall'Era MA; Oudes A; Martin DB; Liu AY
Prostate; 2007 May; 67(7):714-21. PubMed ID: 17342744
[TBL] [Abstract][Full Text] [Related]
10.
Kaikkonen E; Ettala O; Nikulainen I; Taimen P; Lehtinen I; Boström PJ; Kellokumpu-Lehtinen PL; Schleutker J
Anticancer Res; 2019 Oct; 39(10):5353-5359. PubMed ID: 31570429
[TBL] [Abstract][Full Text] [Related]
11. ANO7 African-ancestral genomic diversity and advanced prostate cancer.
Jiang J; Soh PXY; Mutambirwa SBA; Bornman MSR; Haiman CA; Hayes VM; Jaratlerdsiri W
Prostate Cancer Prostatic Dis; 2023 Sep; ():. PubMed ID: 37749167
[TBL] [Abstract][Full Text] [Related]
12. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
13. Important role of SUMOylation of Spliceosome factors in prostate cancer cells.
Wen D; Xu Z; Xia L; Liu X; Tu Y; Lei H; Wang W; Wang T; Song L; Ma C; Xu H; Zhu W; Chen G; Wu Y
J Proteome Res; 2014 Aug; 13(8):3571-82. PubMed ID: 25027693
[TBL] [Abstract][Full Text] [Related]
14. The Proteome of Primary Prostate Cancer.
Iglesias-Gato D; Wikström P; Tyanova S; Lavallee C; Thysell E; Carlsson J; Hägglöf C; Cox J; Andrén O; Stattin P; Egevad L; Widmark A; Bjartell A; Collins CC; Bergh A; Geiger T; Mann M; Flores-Morales A
Eur Urol; 2016 May; 69(5):942-52. PubMed ID: 26651926
[TBL] [Abstract][Full Text] [Related]
15. Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cells.
Mi Y; Sun C; Wei B; Sun F; Guo Y; Hu Q; Ding W; Zhu L; Xia G
Biochem Biophys Res Commun; 2018 Jan; 495(1):473-480. PubMed ID: 29129687
[TBL] [Abstract][Full Text] [Related]
16. Identification of a potential tumor differentiation factor receptor candidate in prostate cancer cells.
Sokolowska I; Woods AG; Gawinowicz MA; Roy U; Darie CC
FEBS J; 2012 Jul; 279(14):2579-94. PubMed ID: 22613557
[TBL] [Abstract][Full Text] [Related]
17. Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells.
Lim JT; Piazza GA; Pamukcu R; Thompson WJ; Weinstein IB
Clin Cancer Res; 2003 Oct; 9(13):4972-82. PubMed ID: 14581372
[TBL] [Abstract][Full Text] [Related]
18. Effects of combined treatment of chemotherapeutics and hyperthermia on survival and the regulation of heat shock proteins in Dunning R3327 prostate carcinoma cells.
Roigas J; Wallen ES; Loening SA; Moseley PL
Prostate; 1998 Feb; 34(3):195-202. PubMed ID: 9492848
[TBL] [Abstract][Full Text] [Related]
19. β-TrCP upregulates HIF-1 in prostate cancer cells.
Cohen M; Amir S; Golan M; Ben-Neriah Y; Mabjeesh NJ
Prostate; 2019 Mar; 79(4):403-413. PubMed ID: 30488478
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes.
Mambula SS; Calderwood SK
J Immunol; 2006 Dec; 177(11):7849-57. PubMed ID: 17114456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
